Skip to main content

Page of 2 next disabled
and
  1. Article

    Open Access

    Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors

    Cerebrospinal fluid (CSF) amyloid-beta (Aβ) peptides are predictive biomarkers for Alzheimer’s disease and are proposed as pharmacodynamic markers for amyloid-lowering therapies. However, frequent sampling res...

    Bianca Van Broeck, Maarten Timmers, Steven Ramael in Alzheimer's Research & Therapy (2016)

  2. Article

    Open Access

    The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease

    Depression and psychosis are two of the most severe neuropsychiatric symptoms (NPS) in dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD). Both NPS have negative effects on cognitive performance and ...

    Yannick Vermeiren, Debby Van Dam, Tony Aerts in Alzheimer's Research & Therapy (2015)

Page of 2 next disabled